|SEQ_NO||1||Date of announcement||2022/05/12||Time of announcement||13:36:08|
|Subject||Announcement of TTY Biopharm's unaudited income information in April 2022|
|Date of events||2022/05/12||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/05/12
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $372,304 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $107,669 thousands, and a consolidated income before tax of $120,969 thousands in April 2022; net income attributed to stockholders of the company was $97,122 thousands; EPS is $0.39.
Year-to-date consolidated net sales was $1,409,421 thousands (in NT dollars; unaudited), a consolidated operating profit was $354,226 thousands and consolidated income before tax was $408,217 thousands until April 2022; year-to-date net income attributed to stockholders of the company was $324,630 thousands; EPS is $1.31.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.